# A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)

> **NCT03347188** · PHASE2 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 87 (actual)

## Conditions studied

- Post-Traumatic Headache

## Interventions

- **DRUG:** Fremanezumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03347188
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-18
- **Primary completion:** 2020-03-13
- **Final completion:** 2020-06-03
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2022-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03347188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03347188, "A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03347188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*